Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Real-world data on the effectiveness of upadacitinib on atopic dermatitis (AD), hand eczema (HE) and HE in the context of AD are limited.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Contact Dermatitis

Title: Contact dermatitis

Publisher: Wiley

ISSN (Electronic): 1600-0536

ISSN (Print): 0105-1873

Publication date (Electronic): May 2023

Volume: 88

Issue: 5

Affiliations

[1 ] Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

[2 ] Department of Dermatology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.

Article

DOI: 10.1111/cod.14276

PubMed ID: 36621910

SO-VID: e124fac7-5c30-400c-b940-5f042c5e08ee

History

Keywords: hand eczema,upadacitinib,treatment,quality of life,atopic dermatitis

Data availability:

Keywords: hand eczema, upadacitinib, treatment, quality of life, atopic dermatitis

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 6

See all cited by